NVST logo

Envista Holdings (NVST)

Profile

Full Name

Envista Holdings Corporation

Ticker Symbol

NVST

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

September 18, 2019

Indexes

Not included

Website

http://envistaco.com

Employees

12300

Key Details

Price

$15.55(-5.38%)

Market cap

$2.68B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.51B(-2.18% YoY)

Annual EPS

-$6.50(-983.33% YoY)

PE ratio

-

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$15.55
NVST price is $15.55

30-Day Relative Volume

0.76
NVST 30-day relative volume is 0.76

Price Performance

Price Today change

-5.38%
NVST price is down -5.38% today

Price YTD change

-19.36%
NVST price is down -19.36% since January 1st

Price 1-year change

-22.65%
NVST price is down -22.65% year-on-year

Price 3-year change

-66.28%
NVST price is down -66.28% over the past 3 years

Price Range

Price All-time high

$52.03
NVST price is currently -70.10% below its historical high of $52.03

Price 3-year low

$14.22
NVST price is currently +9.39% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.68B
NVST market capitalization is $2.68 billion

Market cap 3-year change

-64.29%
NVST market capitalization is down -64.29% over the past 3 years

Market cap All-time high

$8.24B
NVST market capitalization is currently -67.48% below its historical high of $8.24 billion

Market cap sector rank

86.28%
NVST market capitalization is higher than 86.28% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.17%
NVST shares outstanding is up +0.17% year-on-year

Shares Outstanding 3-Year Change

+5.9%
NVST shares outstanding is up +5.9% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.11
NVST beta is 1.11

200-day SMA

$18.71
NVST price is currently -16.86% below its 200-day simple moving average

50-day SMA

$18.81
NVST price is currently -17.32% below its 50-day simple moving average

RSI

44.58
NVST 14-day relative strength index is 44.58

Volume

0.76
NVST 30-day relative volume is 0.76

ATR

$1.19
NVST average true range is $1.19

10-day Historical Volatility

87.09%
NVST 10-day historical volatility is 87.09%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.51B
NVST annual revenue is $2.51 billion

Revenue Analysts estimate

$2.52B
NVST annual revenue is currently -0.34% lower than the consensus analysts' forecast

Revenue 1-year change

-2.18%
NVST annual revenue is down -2.18% year-on-year

Revenue Sector rank

86.56%
NVST annual revenue is higher than 86.56% of companies in Healthcare sector

EPS

EPS

-$6.50
NVST annual earnings per share is -$6.50

EPS Analysts estimate

$0.99
NVST annual earnings per share is currently -755.04% lower than the consensus analysts' forecast

EPS 1-year change

-983.33%
NVST annual earnings per share is down -983.33% year-on-year

EPS Sector rank

15.85%
NVST annual earnings per share is higher than 15.85% of companies in Healthcare sector

Profit

Gross profit

$1.37B
NVST annual gross profit is $1.37 billion

Gross margin

54.68%
NVST annual gross profit margin is 54.68%

Operating profit

$115.60M
NVST annual operating income is $115.60 million

Operating margin

4.60%
NVST annual operating profit margin is 4.60%

Net income

-$1.12B
NVST annual net profit is -$1.12 billion

Net margin

-44.56%
NVST annual net profit margin is -44.56%

Expenses

Total expenses

$2.40B
NVST annual total expenses is $2.40 billion

Operating expenses

$1.26B
NVST annual total operating expenses is $1.26 billion

Cost of goods sold

$1.14B
NVST annual cost of goods sold is $1.14 billion

Selling, general & administrative expenses

$1.16B
NVST annual SGA is $1.16 billion

Depreciation and amortization

$154.50M
NVST annual depreciation & amortization is $154.50 million

Interest expense

$46.40M
NVST annual interest expense is $46.40 million

Income tax

$33.90M
NVST annual income tax is $33.90 million

EBIT & EBITDA

EBIT

-$1.04B
NVST annual earnings before interest & taxes is -$1.04 billion

EBITDA

-$883.80M
NVST annual EBITDA is -$883.80 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.35B
NVST annual total assets is $5.35 billion

Non current assets

$3.56B
NVST annual long term assets is $3.56 billion

Current assets

$1.79B
NVST annual total current assets is $1.79 billion

Cash and cash equivalents

$1.07B
NVST annual cash & cash equivalents is $1.07 billion

Accounts receivable

$363.00M
NVST annual accounts receivable is $363.00 million

Inventory

$241.00M
NVST annual inventory is $241.00 million

Liabilities

Total liabilities

$2.42B
NVST annual total liabilities is $2.42 billion

Long term liabilities

$1.54B
NVST annual total long term liabilities is $1.54 billion

Current liabilities

$878.70M
NVST annual total current liabilities is $878.70 million

Accounts payable

$174.60M
NVST annual accounts payable is $174.60 million

Debt

Total debt

$1.55B
NVST annual total debt is $1.55 billion

Total debt 1-year change

-6.4%
NVST annual total debt is down -6.4% year-on-year

Long term debt

$1.40B
NVST annual long term debt is $1.40 billion

Short term debt

$150.50M
NVST annual short term debt is $150.50 million

Equity & Capital

Shareholders equity

$2.93B
NVST annual stockholders equity is $2.93 billion

Book value

$2.93B
NVST annual book value is $2.93 billion

Retained earnings

-$487.40M
NVST annual retained earnings is -$487.40 million

Working capital

$909.60M
NVST annual working capital is $909.60 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$336.50M
NVST annual cash flow from operations is $336.50 million

Cash from operations 1-year change

+22.05%
NVST annual cash flow from operations is up +22.05% year-on-year

Cash from investing

-$54.60M
NVST annual cash flow from investing activities is -$54.60 million

Cash from investing 1-year change

+12.5%
NVST annual cash flow from investing activities is up +12.5% year-on-year

Cash from financing

-$103.70M
NVST annual cash flow from financing activities is -$103.70 million

Cash from financing 1-year change

-187.22%
NVST annual cash flow from financing activities is down -187.22% year-on-year

CAPEX

CAPEX

$33.80M
NVST annual capital expenditures is $33.80 million

CAPEX 1-year change

-41.92%
NVST annual capital expenditures is down -41.92% year-on-year

Free Cash Flow

Free cash flow

$302.70M
NVST annual free cash flow is $302.70 million

Free cash flow 1-year change

+39.17%
NVST annual free cash flow is up +39.17% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

54.68%
NVST annual gross profit margin is 54.68%

Operating margin

4.60%
NVST annual operating profit margin is 4.60%

Net margin

-44.56%
NVST annual net profit margin is -44.56%

ROA & ROE

ROA

-18.71%
NVST annual return on assets is -18.71%

ROE

-31.47%
NVST annual return on equity is -31.47%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NVST price to earnings ratio value is unknown

PE ratio Sector rank

-
NVST price to earnings ratio is unknown

PB Ratio

PB ratio

0.91
NVST price to book ratio is 0.91

PB ratio Sector rank

43.17%
NVST price to book ratio is higher than 43.17% of companies in Healthcare sector

PS Ratio

PS ratio

1.07
NVST price to sales ratio is 1.07

PS ratio Sector rank

28.97%
NVST price to sales ratio is higher than 28.97% of companies in Healthcare sector

Enterprise value

Enterprise value

$3.16B
NVST enterprise value is $3.16 billion

Enterprise value Sector rank

85.74%
NVST enterprise value is higher than 85.74% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.57
NVST EV/EBITDA is -3.57

EV/EBITDA Sector rank

21.88%
NVST EV/EBITDA is higher than 21.88% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.04
NVST annual current ratio is 2.04

Quick ratio

1.76
NVST annual quick ratio is 1.76

Leverage

Debt to equity

0.48
NVST annual debt to equity ratio is 0.48

Interest coverage ratio

-22.38
NVST annual interest coverage ratio is -22.38

Risk & Stability

Piotroski F-Score

5
NVST piotroski f-score is 5

Altman Z-Score

0.57
NVST altman z-score is 0.57

Analyst ratings

Recent major analysts updates

Mar 10, 25 UBS
Neutral
Mar 6, 25 Needham
Hold
Mar 6, 25 Morgan Stanley
Equal-Weight
Mar 6, 25 JP Morgan
Neutral
Feb 25, 25 Needham
Hold
Feb 6, 25 Wells Fargo
Equal-Weight
Feb 6, 25 Needham
Hold
Feb 6, 25 Morgan Stanley
Equal-Weight
Feb 3, 25 Piper Sandler
Neutral
Jan 23, 25 Jefferies
Hold

Institutional Ownership

Similar stocks

SWTX logo
SpringWorks Therapeutics (SWTX)
PRVA logo
Privia Health (PRVA)
PDCO logo
Patterson Companies (PDCO)
CPRX logo
Catalyst Pharmaceuticals (CPRX)
SLNO logo
Soleno Therapeutics (SLNO)
SGRY logo
Surgery Partners (SGRY)
MRUS logo
Merus NV (MRUS)
ZLAB logo
Zai Lab Limited (ZLAB)
GeneDx Holdings (WGS)
  • What is the ticker symbol for Envista Holdings?
  • Does Envista Holdings pay dividends?
  • What sector is Envista Holdings in?
  • What industry is Envista Holdings in?
  • What country is Envista Holdings based in?
  • When did Envista Holdings go public?
  • Is Envista Holdings in the S&P 500?
  • Is Envista Holdings in the NASDAQ 100?
  • Is Envista Holdings in the Dow Jones?
  • When was Envista Holdings's last earnings report?
  • When does Envista Holdings report earnings?
  • Should I buy Envista Holdings stock now?

What is the ticker symbol for Envista Holdings?

The ticker symbol for Envista Holdings is NYSE:NVST

Does Envista Holdings pay dividends?

No, Envista Holdings does not pay dividends

What sector is Envista Holdings in?

Envista Holdings is in the Healthcare sector

What industry is Envista Holdings in?

Envista Holdings is in the Medical Instruments & Supplies industry

What country is Envista Holdings based in?

Envista Holdings is headquartered in United States

When did Envista Holdings go public?

Envista Holdings's initial public offering (IPO) was on September 18, 2019

Is Envista Holdings in the S&P 500?

No, Envista Holdings is not included in the S&P 500 index

Is Envista Holdings in the NASDAQ 100?

No, Envista Holdings is not included in the NASDAQ 100 index

Is Envista Holdings in the Dow Jones?

No, Envista Holdings is not included in the Dow Jones index

When was Envista Holdings's last earnings report?

Envista Holdings's most recent earnings report was on Feb 5, 2025

When does Envista Holdings report earnings?

The next expected earnings date for Envista Holdings is May 1, 2025

Should I buy Envista Holdings stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page